Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Benjamin Heyman"'
Publikováno v:
Hematology Reports, Vol 15, Iss 4, Pp 627-633 (2023)
Diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma (AITL) are two subtypes of non-Hodgkin lymphoma (NHL). The simultaneous occurrence of DLBCL and AITL in a composite lymphoma is very rare, and there are no established treat
Externí odkaz:
https://doaj.org/article/9b4035d367ca43838e0b0276a532fc27
Autor:
Gregory A Daniels, Jie Jia, Ezra Cohen, Hong Ma, Michael Hahn, Aaron Miller, Dan Kaufman, Joseph Chao, Gloria Sierra, Peter Vu, Zonghai Li, Gregory P Botta, Amanda Y Hendrix, Joy V Nolte Fong, Audrey Ween, Michael Choi, Benjamin Heyman, Catriona Jamieson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Treatment of hematologic malignancies with patient-derived anti-CD19 chimeric antigen receptor (CAR) T-cells has demonstrated long-term remissions for patients with otherwise treatment-refractory advanced leukemia and lymphoma. Conversely, CAR T-cell
Externí odkaz:
https://doaj.org/article/f38deb0f3aa1430ba7b28a13eded7e0a
Publikováno v:
Case Reports in Hematology, Vol 2024 (2024)
Hodgkin lymphoma variant of Richter’s transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the c
Externí odkaz:
https://doaj.org/article/76689a3d37e54650ba260a4c78567ae6
Autor:
Benjamin Heyman, Yiping Yang
Publikováno v:
Cancer Biology & Medicine, Vol 15, Iss 3, Pp 189-209 (2018)
The development of immunotherapies for lymphoma has undergone a revolutionary evolution over the past decades. Since the advent of rituximab as the first successful immunotherapy for B-cell non-Hodgkin lymphoma over two decades ago, a plethora of new
Externí odkaz:
https://doaj.org/article/d6edb19c132440e18ddb7b00f84d1fee
Publikováno v:
Case Reports in Hematology, Vol 2019 (2019)
Mycosis fungoides, along with Sezary syndrome, is the most common subtype of cutaneous T-cell lymphoma. In this report, we present a patient with advanced-stage mycosis fungoides, who after successful treatment of methicillin-resistant Staphylococcus
Externí odkaz:
https://doaj.org/article/ed64073982b04cb6b7dcc1538925600b
Publikováno v:
Blood. 140:12414-12415
Publikováno v:
Blood. 140:12410-12411
Autor:
Tamer Othman, Aaron S Rosenberg, John Timmerman, Benjamin Heyman, Haifaa Abdulhaq, Joseph M Tuscano
Publikováno v:
Blood. 140:11954-11955
Publikováno v:
Cancers, Vol 12, Iss 842, p 842 (2020)
Cancers
Cancers
Chimeric antigen receptors (CAR) are fusion proteins engineered from antigen recognition, signaling, and costimulatory domains that can be used to reprogram T cells to specifically target tumor cells expressing specific antigens. Current CAR-T cell t
Autor:
Anne W. Beaven, David J. Adams, Benjamin Heyman, Joseph O. Moore, David A. Rizzieri, Carlos M. de Castro, Zhiguo Li, Louis F. Diehl
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:679-686
Background For patients with aggressive lymphomas who relapse after initial therapy, a durable response is rarely achieved with standard salvage therapies. Significant efforts have focused on the development of novel treatments with reduced toxicity.